Postdoctoral Fellow

vor 2 Monaten


Stuttgart, Deutschland Universitätsklinikum Tübingen Vollzeit

The University Hospital of Tübingen is a leading center of German university medicine. Every year, around 75,000 inpatients and around 380,000 outpatients are treated. With around 10,000 employees, it is the largest employer in the region. The quality of patient care is certified with the KTQ seal of approval.
The Centre for Genetic Epidemiology (CGE) within Institute for Clinical Epidemiology and Applied Biometry is looking for

**Postdoctoral fellow (f/m/d)**:
with expertise from diverse backgrounds such as genetic epidemiology, statistical genetics, mathematics, and bioinformatics. The part-time-position (65 %) is available as soon as possible and is offered for 3 year with further extension expected.

CGE has a long-standing experience in studying the genetic architecture of complex diseases including neurodegenerative diseases using state-of-the-art approaches such as exome/genome sequencing, Mendelian randomization, machine learning, artificial intelligence, deep learning, etc.

We seek to unravel the role of common and rare variants in Parkinson’s disease by utilizing a variety of genetic epidemiological approaches. A variety of techniques including next-generation sequencing, machine learning, Bayesian approaches, and the use of standard statistical-genetics packages such as PLINK, SKAT, and meta-analytical approaches will be applied to understand the genetic etiology of PD. CGE is a part of multinational consortia and has access to high-quality next-generation sequencing data.

For informal enquiries, please contact PD Dr. Manu Sharma.

**Kontakt bei Fragen**:
**Mr. PD Dr. Manu Sharma**
Tel.: 07071 29-78259

**Bewerbungsfrist: 26.03.2023**
Wir freuen uns auf die Bewerbung an **Mr. PD Dr. Manu Sharma**
mit Lebenslauf und Motivationsschreiben unter Angabe der **Kennziffer 2407**.


  • Research Scientist

    vor 1 Woche


    Stuttgart, Deutschland CureVac Vollzeit

    CureVac SE is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, all _RNA people _are striving to achieve our main goal: To bring multiple best-in-class mRNA drugs to...